The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
2SEVENTY BIO INC COMMON STOCK 901384107   14,371 1,408,901 SH   SOLE   1,408,901 0 0
ACLARIS THERAPEUTICS INC COM 00461U105   27,506 3,400,000 SH   SOLE   3,400,000 0 0
AEGLEA BIOTHERAPEUTICS INC COM 00773J103   1,551 5,347,689 SH   SOLE   5,347,689 0 0
ANNEXON INC COM 03589W102   18,813 4,886,616 SH   SOLE   4,886,616 0 0
APTINYX INC COM 03836N103   1,110 8,891,758 SH   SOLE   8,891,758 0 0
ARCUTIS BIOTHERAPEUTICS INC COM 03969K108   33,000 3,000,000 SH   SOLE   3,000,000 0 0
ATEA PHARMACEUTICALS INC COM 04683R106   8,327 2,485,638 SH   SOLE   2,485,638 0 0
C4 THERAPEUTICS INC COM STK 12529R107   5,157 1,642,210 SH   SOLE   1,642,210 0 0
CARA THERAPEUTICS INC COM 140755109   10,824 2,204,449 SH   SOLE   2,204,449 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107   37,027 2,305,558 SH   SOLE   2,305,558 0 0
CTI BIOPHARMA CORP COM 12648L601   19,753 4,702,996 SH   SOLE   4,702,996 0 0
CYMABAY THERAPEUTICS INC COM 23257D103   21,800 2,500,000 SH   SOLE   2,500,000 0 0
DISC MEDICINE INC COM 254604101   42,187 1,990,914 SH   SOLE   1,990,914 0 0
DYNAVAX TECHNOLOGIES CORP COM NEW 268158201   38,406 3,915,000 SH   SOLE   3,915,000 0 0
EQRX INC COM 26886C107   19,407 10,003,573 SH   SOLE   10,003,573 0 0
INVIVYD INC COM 00534A102   2,325 1,937,207 SH   SOLE   1,937,207 0 0
MARINUS PHARMACEUTICALS INC COM NEW 56854Q200   9,874 1,431,058 SH   SOLE   1,431,058 0 0
MERSANA THERAPEUTICS INC COM 59045L106   35,608 8,663,673 SH   SOLE   8,663,673 0 0
NATERA INC COM 632307104   38,875 700,197 SH   SOLE   700,197 0 0
NAUTILUS BIOTECHNOLOGY INC COM 63909J108   5,540 2,000,000 SH   SOLE   2,000,000 0 0
NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES N62509109   110,058 8,300,000 SH   SOLE   8,300,000 0 0
NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 N62509117   184 100,000 SH   SOLE   100,000 0 0
NURIX THERAPEUTICS INC COM 67080M103   16,187 1,822,883 SH   SOLE   1,822,883 0 0
NUVALENT INC COM 670703107   93,331 3,577,267 SH   SOLE   3,577,267 0 0
PHARVARIS N V COM N69605108   25,620 3,180,601 SH   SOLE   3,180,601 0 0
RAPID MICRO BIOSYSTEMS INC CLASS A COM 75340L104   11,049 8,434,560 SH   SOLE   8,434,560 0 0
SAVARA INC COM 805111101   22,664 11,622,598 SH   SOLE   11,622,598 0 0
SOLID BIOSCIENCES INC COM NEW 83422E204   14,838 3,130,422 SH   SOLE   3,130,422 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107   79,313 3,081,307 SH   SOLE   3,081,307 0 0
SYROS PHARMACEUTICALS INC COM NEW 87184Q206   5,673 2,124,694 SH   SOLE   2,124,694 0 0
TANGO THERAPEUTICS INC COM 87583X109   7,591 1,921,790 SH   SOLE   1,921,790 0 0
THIRD HARMONIC BIO INC COM 88427A107   2,639 640,631 SH   SOLE   640,631 0 0
X4 PHARMACEUTICALS INC COM 98420X103   10,616 12,202,510 SH   SOLE   12,202,510 0 0
XILIO THERAPEUTICS INC COM 98422T100   8,893 2,805,413 SH   SOLE   2,805,413 0 0